Hospital Infection Prevention And Control Market By Infection (Pneumonia, Urinary Tract Infection, Blood Stream Infection, Surgical Site Infection, MRSA), By Product (Infection Prevention Supplies, Infection Prevention Equipment, Infection Prevention Services) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2024

Market Insights

In all countries, hospital-acquired infections are a growing source of preventable disease burden in terms of morbidity and mortality. It has a significant negative impact on healthcare costs, particularly in developing countries. The cost may be direct (the cost of medicines, bed occupation, etc.) or indirect (as patients are deprived of work). According to a WHO study, 55 hospitals in 14 countries in Southeast Asia, Europe, the Eastern Mediterranean, and the Western Pacific revealed that, on average, 8.7% of hospital patients suffer nosocomial infections.

Globally, at least 1 in 4 patients in intensive care will acquire an infection during their stay in the hospital. As a result, strict guidelines are being provided to prevent and control hospital infection. The WHO and various other regulatory bodies at regional and national levels provide guidelines for hospital infection prevention and control. The rising prevalence of nosocomial infections and regulatory guidelines and measures are the driving factors of the global hospital infection prevention and control market.

The report titled “Global Hospital Infection Prevention and Control Market: Growth, Share, Opportunities, and Competitive Analysis, 2016–2024” offers strategic insights into the overall hospital infection prevention and control market, along with the market size and estimates for the duration of 2016–2024.

The said research study covers an in-depth analysis of multiple market segments based on the type of infection, products, and different geographies. The infection type segment studied for analyzing the overall global hospital infection prevention, and control market is majorly segmented into pneumonia, urinary tract infection, bloodstream infection, surgical site infection, MRSA, and others. The product type segment studied for analyzing the global hospital infection prevention and control market is majorly segmented into infection prevention supplies, infection prevention equipment, and infection prevention services.

Geographically, the global hospital infection prevention and control market is studied for the following regional markets:

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • UK.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

The market size and forecast for these regional and country-level markets are presented in this study for the period 2014–2024. Market growth rates for the forecast period 2016–2024 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global hospital infection prevention and control market.

Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the competitive landscape of the global hospital infection prevention and control market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global hospital infection prevention and control market. In-depth competitive environment analysis and historical (2014) market size data are also provided in the report.

Based on the type of product, the global hospital infection prevention and control market is segmented as follows:

• Infection Prevention Supplies

• • Disinfectants
  • Protective apparel and textiles
  • Safety-Enhanced Medical Devices
  • Sterilization Supplies
  • medical waste disposal supplies
• Infection Prevention Equipment
  • Endoscope Reprocessors
  • Sterilization Equipment
  • Washing/Disinfecting Equipment
  • other infection prevention equipment
• Infection Prevention Services
  • medical waste disposal services
  • contract sterilization services
  • Infection Prevention Equipment
  • Infection Prevention Services

In 2015, infection prevention supplies held the largest share of the overall hospital infection prevention and control market. The disinfectants market is expanding as the importance of infection control and sterilization policies in hospitals grows, as make government regulations govern healthcare services. The protective apparel and textile market held the largest share in the infection prevention supplies market due to aggressive efforts by hospitals to reduce the risk of hospital-acquired infections in surgery and other invasive procedures.

As infection-control equipment continues to play an important role in the prevention of infection transmission in the healthcare settings infection prevention services include regular infection prevention activities within the hospital that work closely with the microbiology laboratory and other critical medical departments. The major types of infection prevention services include medical waste disposal and contract sterilization services.

Based on the type of infection, the global hospital infection and control market is segmented as follows:

• Pneumonia
• Infection of the Urinary Tract
• bloodstream infection
• Surgical site infection
• MRSA
• Others

Pneumonia, urinary tract infection (UTI), surgical site infection (SSI), and MRSA are the major types of hospital-acquired infections with the highest prevalence. As sourced by the CDC, ventilator-associated pneumonia and surgical site infection are the most common conditions, followed by GI infection, UTI, and primary bloodstream infection.

The CDC also reported that device-associated infections such as pneumonia, catheter-associated UTIs, and central catheter-associated bloodstream infections accounted for one-fourth of total HAIs. Approximately half of HAIs are device-associated and surgical site infections, and the rest are not linked to devices or operative apparatuses.

For the purpose of this study, the global hospital infection and control market is geographically categorized into:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

Due to the rising prevalence of nosocomial infections and stringent regulations followed by hospitals, clinicians, and caregivers aligning with regulatory bodies, North America formed the largest regional market for hospital infection prevention and control in 2015. With increased awareness of healthcare-associated infection, rising investment in healthcare infrastructure, technological advancement, and new protocols and programs for infection prevention and control in accordance with WHO guidelines, Asia Pacific is the fastest-growing segment.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Hospital Infection Prevention & Control Market Portraiture
2.2 Global Hospital Infection Prevention & Control Market, by Infection Type, 2015 & 2024 (Value %)
2.3 Global Hospital Infection Prevention & Control Market, by Product Type, 2015 (US$ Bn)
2.4 Global Hospital Infection Prevention & Control Market, by Geography, 2015 (Value %)

Chapter 3 Global Hospital Infection Prevention and Control Market Overview
3.1 Market Definition and Scope
3.1.1 Drivers
3.1.1.1 Rise in hospital acquired infection
3.1.1.2 Regulatory guidelines for Hospital Infection Prevention and Control
3.2 Challenges
3.2.1.1 Lack of Awareness of hospital infection prevention and control
3.2.2 Opportunities
3.2.2.1 Emerging economies increase number of hospital
3.2.2.2 Advancement in sterilization technology
3.3 Attractive Investment Proposition
3.4 Competitive Analysis: Global Hospital Infection Prevention and Control Market, 2015 (Value %)

Chapter 4 Global Hospital Infection Prevention and Control Market, by Infection Type
4.1 Overview
4.2 Pneumonia
4.3 Urinary Tract Infection
4.4 Blood Stream Infection
4.5 Surgical Site Infection
4.6 MRSA
4.7 Others

Chapter 5 Global Hospital Infection Prevention & Control Analysis, by Product
5.1 Introduction
5.2 Infection Prevention Supplies
5.2.1 Disinfectants
5.2.1.1 Hand Disinfectants
5.2.1.2 Skin Disinfectants
5.2.1.3 Instrument Disinfectants
5.2.1.4 Surface Disinfectants
5.2.2 Protective Apparel & Textiles
5.2.2.1 Medical & Laboratory Gloves
5.2.2.1.1 Examination Gloves
5.2.2.1.2 Surgical Gloves
5.2.2.1.3 Laboratory Gloves
5.2.2.2 Surgical Drapes
5.2.2.2.1 Nonwoven Drapes
5.2.2.2.2 Plastic Drapes
5.2.2.2.3 Woven Drapes
5.2.2.3 Surgical Gowns
5.2.2.4 Patient Gowns
5.2.2.5 Surgical & Staff Face Masks
5.2.2.6 Other Protective Apparel & Textile
5.2.2.6.1 Disposable Staff Apparel
5.2.2.6.2 Disposable Towels & Bedding
5.2.3 Safety-Enhanced Medical Devices
5.2.3.1 Safety-Enhanced Syringes
5.2.3.1.1 Prefillable Syringes
5.2.3.1.2 Safety-Enhanced Clinical Syringes
5.2.3.2 Safety-Enhanced Catheters
5.2.3.2.1 IV Catheter
5.2.3.2.2 Urinary Catheter
5.2.3.3 Safety-Enhanced Blood Collection Tubes
5.2.3.4 Other Safety-Enhanced Medical Devices
5.2.4 Sterilization Supplies
5.2.4.1 Sterile Containers
5.2.4.2 Sterilization Wrap
5.2.4.3 Sterilization Indicators
5.2.5 Medical Waste Disposal Supplies
5.2.5.1 Medical Waste Disposal Containers
5.2.5.2 Medical Waste Disposal Accessories
5.3 Infection Prevention Equipment
5.3.1 Endoscope Reprocessors
5.3.2 Sterilization Equipment
5.3.2.1 Heat Sterilization
5.3.2.2 Low-Temperature Sterilization
5.3.2.3 Filtration Sterilization
5.3.2.4 Radiation Sterilization
5.3.3 Washing/Disinfecting Equipment
5.3.4 Other Infection Prevention Equipment
5.3.4.1 Infectious Waste Receptacles
5.3.4.2 Infectious Waste Processing Units
5.4 Infection Prevention Services
5.4.1 Medical Waste Disposal Services
5.4.2 Contract Sterilization Services

Chapter 6 Global Hospital Infection Prevention and Control Market, By Geography
6.1 Preface
6.2 North America (U.S. &Canada)
6.2.1 North America Hospital Infection Prevention & Control Market, By Products & Services
6.2.1.1 Infection Prevention Supplies
6.2.1.2 Infection Prevention Equipment
6.2.1.3 Infection Prevention Services
6.2.2 North America Hospital Infection Prevention and Control Market, By Country
6.2.2.1 USA
6.2.2.2 Canada
6.3 Europe (U.K., Germany, & Rest of Europe)
6.3.1 Europe Hospital Infection Prevention and Control Market , By Products & Services
6.3.1.1 Infection Prevention Supplies
6.3.1.2 Infection Prevention Equipment
6.3.1.3 Infection Prevention Services
6.3.2 Europe Hospital Infection Prevention and Control Market , By Country
6.3.2.1 UK
6.3.2.2 Germany
6.3.2.3 Rest of Europe
6.4 Asia Pacific (China, Japan and Rest of Asia Pacific)
6.4.1 Asia Pacific Hospital Infection Prevention & Control, By Products & Services
6.4.1.1 Infection Prevention Supplies
6.4.1.2 Infection Prevention Equipment
6.4.1.3 Infection Prevention Services
6.4.1 Asia Pacific Hospital Infection Prevention & Control, By Country
6.4.1.1 China
6.4.1.2 Japan
6.4.1.3 Rest of Asia Pacific
6.5 Latin America (Brazil, Mexico and Rest of Latin America)
6.5.1 Latin America Hospital Infection Prevention and Control Market, By Products & Services
6.5.1.1 Infection Prevention Supplies
6.5.1.2 Infection Prevention Equipment
6.5.1.3 Infection Prevention Services
6.5.2 Latin America Hospital Infection Prevention and Control Market, By Country
6.5.2.1 Mexico
6.5.2.2 Brazil
6.5.2.3 Rest of Latin America
6.6 Middle East and Africa

Chapter 7 Company Profiles
7.1 3M Company
7.2 Ansell Ltd.
7.3 Becton, Dickinson and Company
7.4 Belimed AG
7.5 Bemis Company, Inc.
7.6 B. Braun Melsungen AG
7.7 Cantel Medical Corp.
7.8 Cardinal Health, Inc.
7.9 Covidien plc.
7.10 Crosstex International, Inc.
7.11 Danaher Corp.
7.12 Diversey, Inc.
7.13 Getinge Group
7.14 Johnson & Johnson
7.15 Halyard Health, Inc.
7.16 MMM Group
7.17 Matachana Group
7.18 Medivators, Inc.
7.19 Purdue Pharma LP
7.20 Sealed Air Corp.
7.21 Semperit AG Holding
7.22 Synergy Health plc.
7.23 Terumo Corp.

List of Figures

FIG. 1 Hospital Infection Prevention & Control Market: Research Methodology
FIG. 2 Global Hospital Infection Prevention & Control Market, by Infection Type, 2015 & 2024 (Value %)
FIG. 3 Global Hospital Infection Prevention & Control Market, by Product Type, 2015 (US$ Bn)
FIG. 4 Global Hospital Infection Prevention & Control Market, by Geography, 2015 (Value %)
FIG. 5 Competitive Analysis: Global Hospital Infection Prevention and Control Market, 2015 (Value %)
FIG. 6 Competitive Analysis: Global Hospital Infection Prevention and Control Market, 2015 (Value %)
FIG. 7 Hospital Acquired Pneumonia Prevention and Control Market, 2014-2024 (US$ Bn)
FIG. 8 Hospital Acquired Urinary Tract Infection Prevention and Control Market, 2014 – 2024 (US$ Bn)
FIG. 9 Hospital Acquired Blood Stream Infection Prevention and Control Market, 2014 – 2024 (US$ Bn)
FIG. 10 Hospital Acquired Surgical Site Infection and Control Market, 2014 – 2024 (US$ Bn)
FIG. 11 Hospital Acquired MRSA Prevention and Control Market, 2014 – 2024 (US$ Bn)
FIG. 12 Hospital Infection Prevention and Control Market for Other Infections, 2014 – 2024 (US$ Bn)
FIG. 13 Hand Disinfectants Market, 2014 – 2024 (US$ Bn)
FIG. 14 Skin Disinfectants Market, 2014 – 2024 (US$ Bn)
FIG. 15 Instrument Disinfectants Market, 2014 – 2024 (US$ Bn)
FIG. 16 Surface Disinfectants Market, 2014 – 2024 (US$ Bn)
FIG. 17 Examination Gloves Market, 2014 – 2024 (US$ Bn)
FIG. 18 Surgical Gloves Market, 2014 – 2024 (US$ Bn)
FIG. 19 Laboratory Gloves Market, 2014 – 2024 (US$ Bn)
FIG. 20 Nonwoven Drapes Market, 2014 – 2024 (US$ Bn)
FIG. 21 Plastic Drapes Market, 2014 – 2024 (US$ Bn)
FIG. 22 Woven Drapes Market, 2014 – 2024 (US$ Bn)
FIG. 23 Surgical Gowns Market, 2014 – 2024 (US$ Bn)
FIG. 24 Patient Gowns Market, 2014 – 2024 (US$ Bn)
FIG. 25 Surgical & Staff Face Masks Market, 2014 – 2024 (US$ Bn)
FIG. 26 Disposable Staff Apparel Market, 2014 – 2024 (US$ Bn)
FIG. 27 Disposable Towels & Bedding Market, 2014 – 2024 (US$ Bn)
FIG. 28 Prefillable Syringes Market, 2014 – 2024 (US$ Bn)
FIG. 29 Safety-Enhanced Clinical Syringes Market, 2014 – 2024 (US$ Bn)
FIG. 30 IV Catheters Market, 2014 – 2024 (US$ Bn)
FIG. 31 Urinary Catheters Market, 2014 – 2024 (US$ Bn)
FIG. 32 Safety-Enhanced Blood Collection Tubes Market, 2014 – 2024 (US$ Bn)
FIG. 33 Other Safety-Enhanced Medical Devices Market, 2014 – 2024 (US$ Bn)
FIG. 34 Sterile Containers Market, 2014 – 2024 (US$ Bn)
FIG. 35 Sterilization Wrap Market, 2014 – 2024 (US$ Bn)
FIG. 36 Sterilization Indicators Market, 2014 – 2024 (US$ Bn)
FIG. 37 Medical Waste Disposal Containers Market, 2014 – 2024 (US$ Bn)
FIG. 38 Medical Waste Disposal Accessories Market, 2014 – 2024 (US$ Bn)
FIG. 39 Endoscope Reprocessors Market, 2014 – 2024 (US$ Bn)
FIG. 40 Heat Sterilization Market, 2014 – 2024 (US$ Bn)
FIG. 41 Low-Temperature Sterilization Market, 2014 – 2024 (US$ Bn)
FIG. 42 Filtration Sterilization Market, 2014 – 2024 (US$ Bn)
FIG. 43 Radiation Sterilization Market, 2014 – 2024 (US$ Bn)
FIG. 44 Washing/Disinfecting Equipment Market, 2014 – 2024 (US$ Bn)
FIG. 45 Infectious Waste Receptacles Market, 2014 – 2024 (US$ Bn)
FIG. 46 Infectious Waste Processing Units Market, 2014 – 2024 (US$ Bn)
FIG. 47 Medical Waste Disposal Services Market, 2014 – 2024 (US$ Bn)
FIG. 48 Contract Sterilization Services Market, 2014 – 2024 (US$ Bn)
FIG. 49 USA Hospital Infection Prevention and Control Market, 2014 – 2024(US$ Bn)
FIG. 50 Canada Hospital Infection Prevention and Control Market, 2014 – 2024(US$ Bn)
FIG. 51 UK Hospital Infection Prevention and Control Market, 2014 – 2024(US$ Bn)
FIG. 52 Germany Hospital Infection Prevention and Control Market, 2014 – 2024(US$ Bn)
FIG. 53 Rest of Europe Hospital Infection Prevention and Control Market, 2014 – 2024(US$ Bn)
FIG. 54 China Hospital Infection Prevention and Control Market, 2014 – 2024(US$ Bn)
FIG. 55 Japan Hospital Infection Prevention and Control Market, 2014 – 2024(US$ Bn)
FIG. 56 Rest of Asia Pacific Hospital Infection Prevention and Control Market, 2014 – 2024(US$ Bn)
FIG. 57 Mexico Hospital Infection Prevention and Control Market, 2014 – 2024(US$ Bn)
FIG. 58 Brazil Hospital Infection Prevention and Control Market, 2014 – 2024(US$ Bn)
FIG. 59 Rest of Latin America Hospital Infection Prevention and Control Market, 2014 – 2024(US$ Bn)
FIG. 60 Middle East and Africa Hospital Infection Prevention and Control Market, 2014 – 2024(US$ Bn)

List of Tables

TABLE 1 Global Hospital Infection Prevention and Control Market Share, by Infection Type, 2014-2024 (US$ Bn)
TABLE 2 Hospital Infection Prevention and Control Market, by Product Type, 2014 – 2024 (US$ Bn)
TABLE 3 Infection Prevention Supplies Market, by Product Type, 2014 – 2024 (US$ Bn)
TABLE 4 Disinfectants Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 5 Protective Apparel & Textiles Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 6 Medical & Laboratory Gloves Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 7 Surgical Drapes Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 8 Other Protective Apparel & Textiles Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 9 Safety-Enhanced Medical Devices Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 10 Safety-Enhanced Syringes Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 11 Safety-Enhanced Syringes Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 12 Sterilization Supplies Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 13 Medical Waste Disposal Supplies Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 14 Infection Prevention Equipment Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 15 Sterilization Equipment Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 16 Other Infection Prevention Equipment Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 17 Infection Prevention Services Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 18 Global Hospital Infection Prevention and Control Market, by Geography, 2014 – 2024 (US$ Bn)
TABLE 19 North America Hospital Infection Prevention and Control Market, by Country, 2013 – 2024 (US$ Bn)
TABLE 20 Infection Prevention Supplies Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 21 Infection Prevention Equipment Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 22 Infection Prevention Services Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 23 Europe Hospital Infection Prevention and Control Market, by Country, 2014 – 2024 (US$ Bn)
TABLE 24 Infection Prevention Supplies Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 25 Infection Prevention Equipment Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 26 Infection Prevention Services Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 27 Asia-Pacific Hospital Infection Prevention and Control Market, by Country, 2014 – 2024 (US$ Bn)
TABLE 28 Asia-Pacific Infection Prevention Supplies Market, by Product Type, 2014 – 2024 (US$ Bn)
TABLE 29 Asia-Pacific Infection Prevention Equipment Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 30 Asia-Pacific Infection Prevention Services Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 31 Latin America Hospital Infection Prevention and Control Market, by Country/Region, 2014 – 2024 (US$ Bn)
TABLE 32 Latin America Infection Prevention Supplies Market, by Product Type, 2014 – 2024 (US$ Bn)
TABLE 33 Latin America Infection Prevention Equipment Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 34 Latin America Infection Prevention Services Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 35 Latin America Infection Prevention Equipment Market, by Type, 2014 – 2024 (US$ Bn)
TABLE 36 3M Company: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 37 Ansell Ltd.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 38 Becton, Dickinson and Company: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 39 Belimed AG: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 40 Bemis Company, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 41 B. Braun Melsungen AG: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 42 Cantel Medical Corp.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 43 Cardinal Health, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 44 Covidien plc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 45 Crosstex International, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 46 Danaher Corp.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 47 Diversey, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 48 Getinge Group: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 49 Johnson & Johnson: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 50 Halyard Health, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 51 MMM Group: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 52 Matachana Group: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 53 Medivators, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 54 Purdue Pharma LP: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 55 Sealed Air Corp.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 56 Semperit AG Holding: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 57 Synergy Health plc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 58 Terumo Corp.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)